Kriya Expands Gene Therapy Pipeline and Establishes its Rare Disease Therapeutic Area Division with the Acquisition of Warden Bio

Portfolio includes five investigational gene therapy programs for glycogen storage disorders that have no existing FDA-approved treatments available Warden Bio Co-Founder Kunal Kishnani joins as President of Kriya’s Rare Disease Division and will lead its overall strategic, development, and partnership activities REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — January 7, 2022 — Kriya Therapeutics, … Continue reading Kriya Expands Gene Therapy Pipeline and Establishes its Rare Disease Therapeutic Area Division with the Acquisition of Warden Bio